Advances in histone demethylase KDM3A as a cancer therapeutic target
J Yoo, YH Jeon, HY Cho, SW Lee, GW Kim, DH Lee… - Cancers, 2020 - mdpi.com
Lysine-specific histone demethylase 3 (KDM3) subfamily proteins are H3K9me2/me1
histone demethylases that promote gene expression. The KDM3 subfamily primarily consists …
histone demethylases that promote gene expression. The KDM3 subfamily primarily consists …
Advances in histone demethylase KDM4 as cancer therapeutic targets
DH Lee, GW Kim, YH Jeon, J Yoo, SW Lee… - The FASEB …, 2020 - Wiley Online Library
Abstract The KDM4 subfamily H3K9 histone demethylases are epigenetic regulators that
control chromatin structure and gene expression by demethylating histone H3K9, H3K36 …
control chromatin structure and gene expression by demethylating histone H3K9, H3K36 …
The diverse roles of histone demethylase KDM4B in normal and cancer development and progression
Z Wang, H Cai, E Zhao, H Cui - Frontiers in Cell and Developmental …, 2022 - frontiersin.org
Histone methylation status is an important process associated with cell growth, survival,
differentiation and gene expression in human diseases. As a member of the KDM4 family …
differentiation and gene expression in human diseases. As a member of the KDM4 family …
[HTML][HTML] Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential
RM Labbé, A Holowatyj… - American journal of …, 2013 - pmc.ncbi.nlm.nih.gov
KDM4 histone demethylases catalyze the removal of methyl marks from histone lysine
residues to epigenetically regulate chromatin structure and gene expression. KDM4 …
residues to epigenetically regulate chromatin structure and gene expression. KDM4 …
Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
J Yoo, GW Kim, YH Jeon, JY Kim, SW Lee… - … & Molecular Medicine, 2022 - nature.com
Distinct epigenetic modifiers ensure coordinated control over genes that govern a myriad of
cellular processes. Growing evidence shows that dynamic regulation of histone methylation …
cellular processes. Growing evidence shows that dynamic regulation of histone methylation …
Recent advances with KDM4 inhibitors and potential applications
Q Wu, B Young, Y Wang, AM Davidoff… - Journal of medicinal …, 2022 - ACS Publications
The histone lysine demethylase 4 (KDM4) family plays an important role in regulating gene
transcription, DNA repair, and metabolism. The dysregulation of KDM4 functions is …
transcription, DNA repair, and metabolism. The dysregulation of KDM4 functions is …
Unravelling KDM4 histone demethylase inhibitors for cancer therapy
S Baby, DG Valapil, N Shankaraiah - Drug discovery today, 2021 - Elsevier
Epigenetic enzyme-targeted therapy is a promising new development in the field of drug
discovery. To date, histone deacetylases and DNA methyltransferases have been …
discovery. To date, histone deacetylases and DNA methyltransferases have been …
Histone demethylase KDM2A: Biological functions and clinical values
L Liu, J Liu, Q Lin - Experimental and Therapeutic …, 2021 - spandidos-publications.com
Histone lysine demethylation modification is a critical epigenetic modification. Lysine
demethylase 2A (KDM2A), a Jumonji C domain‑containing demethylase, demethylates the …
demethylase 2A (KDM2A), a Jumonji C domain‑containing demethylase, demethylates the …
Small molecule KDM4s inhibitors as anti-cancer agents
H Lin, Q Li, Q Li, J Zhu, K Gu, X Jiang… - Journal of Enzyme …, 2018 - Taylor & Francis
Histone demethylation is a vital process in epigenetic regulation of gene expression. A
number of histone demethylases are present to control the methylated states of histone …
number of histone demethylases are present to control the methylated states of histone …
The KDM5 family of histone demethylases as targets in oncology drug discovery
PB Rasmussen, P Staller - Epigenomics, 2014 - Taylor & Francis
There is growing evidence for a causal role of the KDM5 family of histone demethylases in
human cancer. In particular, KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) …
human cancer. In particular, KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) …